Universidad de Granada
Monday, September 24, 2018
Sala de Claustro
Facultad de Ciencias
Campus de Fuentenueva, s/n
Universidad de Granada
ACS on Campus, the American Chemical Society’s flagship outreach program, is proud to partner with Universidad de Granada on September 24! Our sessions will introduce you to publishing and informatics processes, and contribute to your professional development. You’ll benefit from exposure to ACS editors and networking opportunities with local professionals and your peers. Don’t miss out on career advice from local professionals during our Careers in Chemistry panel discussion!
You’ll hear from Prof. Félix Calderon, Associate Editor, ACS Infectious Diseases, Dr. Míriam Plana of ACS International, and more!
The event is FREE and open to all students studying the sciences – not just chemistry! Registration is recommended.
“Tres Cantos Open Lab: Filling the Translational Gap in Neglected Diseases Drug Discovery” from. Dr. Félix Calderón
The drug discovery process for the diseases of the developing world (DDW) in the pharmaceutical industry is challenging due to the large investment and low financial return. Therefore, innovative strategies are required to discover and develop new pharmaceuticals against Diseases of the Developing World.
Since 2010, GlaxoSmithKline has adopted an open innovation strategy promoting collaboration and transfer of knowledge among the scientific community, with the final aim to deliver new effective medicines for the DDW. Within our open innovation approach, the Open Lab program has been created to facilitate the translation of basic research in the DDW field into industrial scale. The Open Lab offers the GSK Tres Cantos site (Spain) to scientists from around the world to work on their own DDW projects, providing them the drug discovery expertise and state-of-the-art facilities of the pharmaceutical industry. Results are shared with the broader community to accelerate and motivate research in DDW.
Over the last seven years, the Open Lab has funded more than 72 projects and has hosted more than 85 visiting scientists from world class institutions. Focused on developing tools, exploiting targets and discovering novel molecules to tackle malaria, tuberculosis, kinetoplastid and enteric diseases, the Openlab is delivering exciting drug discovery opportunities that could deliver new effective medicines for the least developed countries.
Using SciFinder in Your Job Search
Top 10 Tips for Scholarly Publishing
Careers in Chemistry – Panel Discussion
Closing Remarks & ACS Resources to Grow Your Future
Félix Calderón, Ph.D.
Associate Editor, ACS Infectious Diseases
Félix Calderón started his career at GSK in 2007 as medicinal chemist working in the Diseases of the Developing World unit at the Tres Cantos R&D site. Since then, he has hold different leading roles working across the organization at different R&D sites. In 2012 he was appointed manager of the Malaria and in 2018 Head of the Tres Cantos Openlab Foundation. Prior to GSK, his background includes a B.Sc. from the Autonoma University of Madrid and training in synthetic chemistry at the University of Turin (Italy), the Spanish National Council for Scientific Research (CSIC, Ph.D. awarded in 2006), and computational chemistry at the University of California Los Angeles (UCLA). He is associate editor of the American Chemical Society’s Infectious Diseases journal and member of the Fine Chemical Group of the London based Society for Chemistry and Industry (SCI).
Míriam Plana, Ph.D.
Account Manager Spain & Portugal, Chemical Abstracts Service, ACS International
Dr. Míriam Plana joined Chemical Abstracts Service (CAS) in 2007. Her main focus at CAS is helping scientists solve their scientific information challenges and reach their goals through CAS Solutions. Míriam received her Ph.D. in Inorganic Chemistry from the University of Barcelona, where she also completed her undergraduate studies. During her Ph.D. studies she moved to University of Oxford (UK), Technische Universität Berlin (Germany) and BAYER AG (Germany) to complete her research and learn new ways and techniques to do research. Before working at CAS, Míriam worked as a Technical Chemical Engineer, Head of X-Rays Diffraction and Researcher in R&D in different fields such as Cosmetic, Paper, Dyes and Enamels. She speaks English, German, Spanish, Catalan and some French.
Pilar López Varo, Ph.D.
Assistant Professor, University of Granada
Dr. Pilar López Varo received the degree of Electronic Engineer, and Ph.D. degree in Physics from the University of Granada, Granada, Spain, in 2011 and 2017, respectively. During her Ph.D. studies, she moved to McMaster University (Hamilton, Canada) and Universitat Jaume I (Castellon, Spain). She has been working as a researcher and assitant professor in the University of Granada from 2014 to 2018. Currently, she colaborate in several international and national proyects with research groups of McMaster University (Canada), Universitat Jaume I (Spain) and Universitat Rovira i Virgili (Tarragona, Spain). Her current research interests include physio-chemical device modeling of perovskite solar cells and organic solar cells, and the characterization of organic thin film transistors.
Juan J. Giner-Casares, Ph.D.
Ramón y Cajal fellow, University of Córdoba
Dr. Giner-Casares graduated in Chemistry and obtained his PhD in Physical Chemistry at the University of Córdoba (Spain). From 2009 to 2013, Dr. Giner-Casares worked as an Alexander von Humboldt fellow in the Max Planck Institute for Colloids and Interfaces (Germany). In 2013, Dr. Giner-Casares moved to biomaGUNE in Donostia/San Sebastián led by Prof. Dr. Luis Liz-Marzán. Since 2016, Dr. Giner-Casares is working as a “Ramón y Cajal” fellow in the University of Córdoba. Dr. Giner-Casares have published more than 50 papers, having received more than 680 citations. Dr. Giner-Casares is serving as Associate Editor for RSC Advances and has worked in more than 15 research projects, currently leading 2 national projects (Retos and Explora). The main research areas of Dr. Giner-Casares are the bio-nano field and the self-assembly at liquid interfaces.
Juan Carlos Morales, Ph.D.
Instituto de Parasitología y Biomedicina López Neyra de Granada, CSIC
Juan Carlos Morales Sánchez es doctor en Ciencias Químicas por la Universidad Autónoma de Madrid. Fue responsable del área de Química de Puleva Biotech (2000-2006) y desde 2008 es científico titular del CSIC. En 2014 se trasladó al Instituto de Parasitología y Biomedicina López Neyra del PTS Granada. Es autor de más de 80 publicaciones e inventor de 11 patentes. Su investigación se centra principalmente en el estudio de las interacciones moleculares entre biomoléculas y en las fases iniciales del descubrimiento de fármacos para el tratamiento de enfermedades neurodegenerativas y cáncer.
Project Leader – Medicinal Chemistry, ORYZON (Labs)
I obtained my degree in M. Sc from the Universidad of Barcelona, Barcelona, Spain in 1999 and afterwards I was working 1 year in a research group of Universidad of Barcelona in collaboration with the pharmaceutical company Grupo Vita. I joined Almirall Prodesfarma S.A (currently named as ALMIRALL S.A) in 2000 as part of the Combinatorial Chemistry research group holding different roles (drug design, set-up of a semipreparative HPLC, development of new solid phase synthesis technologies). From 2002, I became part the Medicinal Chemistry research group, where I was mainly involved in the design and synthesis of new drugs in several research programs of ALMIRALL. In 2009 I joined ORYZON GENOMICS S.A as Project Leader in Medicinal Chemistry, designing new drugs for epigenetic targets and managing several national and international collaborations